Pharmaceutical Formulations


Formulation studies involve developing a preparation of the drug which is both stable and acceptable to the patient. For orally administered drugs, this usually involves incorporating the drug into a tablet or a capsule. It is important to make the distinction that a tablet contains a variety of other potentially inert substances apart from the drug itself, and studies have to be carried out to ensure that the encapsulated drug is compatible with these other substances in a way that does not cause harm, whether direct or indirect. Formulation studies also consider such factors as particle size, polymorphism, pH, and solubility, as all of these can influence bioavailability and hence the activity of a drug. The drug must be combined with inactive ingredients by a method which ensures that the quantity of drug present is consistent in each dosage unit e.g. each tablet. The dosage should have a uniform appearance, with an acceptable taste, tablet hardness, or capsule disintegration. By the time phase III clinical trials are reached, the formulation of the drug should have been developed to be close to the preparation that will ultimately be used in the market.



 

    Related Conference of Pharmaceutical Formulations

    October 16-17, 2023

    34th World Nano Conference

    Vancouver, Canada
    November 08-09, 2023

    4th World Congress on Nanotechnology and Advanced Materials

    Budapest, Hungary
    December 04-05, 2023

    31st International Conference on Nanomedicine and Nanomaterials

    Prague, Czech Republic
    January 11-12, 2024

    2nd Global Summit on Nanoscience and Technology

    Dubai, UAE
    April 11-12, 2024

    41th Global Nanotechnology Congress

    Amsterdam, Netherlands

    Pharmaceutical Formulations Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in